Tuesday, March 4, 2025

Analysis on Narayana Hrudayalaya

1. About Business:

Business Overview:

Narayana Hrudayalaya (Narayana Health) is one of India’s largest multi-specialty hospital chains, founded by Dr. Devi Shetty in 2000. The company focuses on providing affordable and high-quality healthcare services, particularly in cardiac care and oncology.

Business Model:

  • Operates multi-specialty and single-specialty hospitals across India and a few international locations (e.g., Cayman Islands).
  • Focuses on cost-efficient healthcare through process optimization and economies of scale.
  • Expanding into tertiary and quaternary care services in cardiology, nephrology, neurology, oncology, orthopedics, etc.
  • Uses a hub-and-spoke model—major hospitals act as hubs, while smaller centers (spokes) handle basic care.
2. Most Important thing to look for in Financial Statements.
Income StatementNarayana
Sales Growth10.91% Y-o-Y, 7.26% Q-o-Q
OPM23%
NPM15%
DepreciationGoing Up
Int/Ebitda0.10X
Earnings Growth Last 3 Yeas365%
Balance SheetNarayana
Debt/Equity0.53
CapexYes
WC-9 Days
Sales/Fixed Assets1.2
Cash+Investment329 cr
Debt Burden22.0%
B/S Stronger Over TimeYes

NarayanaMar-21Mar-22Mar-23Mar-24
DU Pont ROE-1%23%28%27%
Net Profit Margin-1%9%13%16%
Sales/Total assets0.931.181.080.89
Financial Leverage2.482.111.961.95
Here are the primary reasons for the increase in EBITDA margins for Narayana Hrudayalaya over the last three years:
  • Focus on Quality Revenue and Improved Payer Mix: Higher profitability from a strategic shift in revenue streams.
  • Operational Efficiencies: Cost reduction and better service delivery.
  • Increased Occupancy and Footfalls: Better utilization of facilities.
  • Higher ARPOB (Average Revenue Per Occupied Bed): Enhanced revenue generation per patient.
  • Turnaround of New Hospitals: Improved performance and profitability of newer facilities.
  • Strategic Expansion: Focus on debottlenecking and expanding high-performing regions.
3. Management Analysis

1. Was there any fraud, financial irregualrities , Sebi related issues in Narayana Hrudhayala
    No
2. Change in Promoter Holding
    No
3. Related Party Transaction
    Not Material
4. Cash Flow GEneration- Cum PATv/s Cum CFO
    Cum PAT 2040 V/s Cum CFO 4315
5. Community Insights

6. Financial Discipline CFO/PAT>80%
    212%

4. Fundamental Analysis
Narayana
1Profitability
-
ROE & ROCE>15 %, If not , can they go above 15%
27%
-
Margins- Fluctuating or Expanding Consistently?
23-28%
2
Operating Dynamics
-Operating Leverage
-Company V/s Peers
-
Is the base favourable for next 2-3 Quarters
Yes
3Cash Flow & Debt
-
Converting Profits into Cash
Yes
-D/E Ratio0.53
4Growth Potential
-
Industry Headwinds/Tailwinds?
Tailwinds
-
What is Variant Perception
DeleveragingNew OrdersAcquisition
Margin ExpansionCost CuttingGovt. Incentives
Better Product MixDemergerHigher VAP
Volume GrowthCapex Live

5. Peer 2 Peer Analysis
ParticularsNarayanaApolloMax
Average Daily Revenue Per Occupied Bed41095.89 Rs59073.0 Rs76200.0 Rs
Hospital Occupancy Rate51.17 %68.0 %78.0 %
Average Length Of Stay4.3 Days3.34 Days4.1 Days
Operational Beds5789.0 .7942.0 .3949.0 .
5 yr Average ROE17.6 %12.37 %7.39 %
P/E34.3888.74107.99
5yr Avg Operating Profit Margin16.76 %12.91 %20.36 %

Profitability RatiosMarch 2015March 2016March 2017March 2018March 2019March 2020March 2021March 2022March 2023March 2024Remarks
Gross Margin (%)NH75.0276.0176.7975.675.9776.1773.7675.4477.8778.6
APOLLOHOSP50.1650.8550.451.0851.5451.1146.1748.3548.3948.55
MAXHEALTH69.4872.273.6975.3778.4579.4876.376.5679.7979.31
Op Profit Margin (%)NH9.2110.9812.189.6510.3113.657.3217.9221.6723.26
The difference is due to employee cost of 16.61 % of Max and 20.15% of NH. therefore , NH has low NPM compared to Max,
APOLLOHOSP14.1910.959.749.611.0514.0610.7314.912.3412.54
MAXHEALTH6.647.228.736.528.68.3715.323.8426.927.4
Net Profit Margin (%)NH-1.231.324.422.252.073.8-0.559.2413.4115.74
APOLLOHOSP6.563.633.051.422.454.041.427.24.934.71
MAXHEALTH-3.27-1.580.98-1.2-0.185.57-5.4815.3724.1919.56
ROE (%)NH-2.182.428.624.965.4710.47-1.2822.9828.4627.38
NH asset turns is 0.89X and Max asset turns is 0.45. Therefore inspite of High NPM of Max its having less ROE .
APOLLOHOSP10.726.786.673.617.0813.623.2718.7713.2212.96
MAXHEALTH-4.46-1.971.32-1.78-0.312.31-2.449.6314.8912.58
 
 6. Risk
  • Supreme Court order on Standardisation of rates
  • Apollo insurance biz was later acquired by HDFC Ergo.
  • Next 3-4 Years slow Growth bcoz of Greenfiled Capex.

Analysis on Inventurus Knowledge Solutions

Most Important thing to look for in Financial Statements
Income StatementIKSBalance SheetIKS
Sales Growth76% Y-o-Y,Debt/Equity0.67X
OPM28%CapexNo, Aquisition made
NPM20-25%WC6 -20days
DepriciationGoing UpSales/Fixed Assets1.0
Int/Ebitda0.11XCash+Investment271 Cr
Earnings Growth Last 3 Yeas31%%Debt Burden33.5%
B/S Stronger Over TimeTripled

 

Dupont ROE
IKSMar-21Mar-22Mar-23Mar-24
DU Pont ROE36.11%36.01%36.79%31.95%
Net Profit Margin29.84%30.50%29.58%20.35%
Sales/Total assets0.940.971.040.63
Financial Leverage1.281.221.192.49

Management Analysis
1. Was there any fraud, financial irregualrities , Sebi related issues in the co?
Recently faced allegations from minority shareholders concerning corporate governance practices and statutory violations
2. Change in Promoter Holding
No
3. Related Party Transaction
Not Material
4. Cash Flow GEneration- Cum PATv/s Cum CFO
Cum PAT 1212 cr V/s Cum CFO 1069 cr
5. Community Insights
Not much info in Valuepickr Forum
6. Financial Discipline CFO/PAT>80%
88.20%

Fundamental Checklist
1Profitability
-
ROE & ROCE>15 %, If not , can they go above 15%
40%
-
Margins- Fluctuating or Expanding Consistently?
Consistent
2OperatingDynamics
-Operating Leverage
Yes, Bcoz of Aquisition
-Company V/s Peers
-
Is the base favourable for next 2-3 Quarters
Yes
3Cash Flow & Debt
-
Converting Profits into Cash
Yes
-D/E Ratio0.67X
4Growth Potential
-
Industry Headwinds/Tailwinds?
11-12% CAGRTailwinds
-
What is Variant Perception
DeleveragingNew OrdersAcquisition
Margin ExpansionCost CuttingGovt. Incentives
Better Product MixDemergerHigher VAP
Volume GrowthCapex Live